Promisia Healthcare Ltd
NZX:PHL
Promisia Healthcare Ltd
NZX:PHL
Price:
0.47
NZD
Market Closed
Market Cap:
NZ$24.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Promisia Healthcare Ltd
NZX:PHL
|
NZ |
|
O
|
Optima Automobile Group Holdings Ltd
HKEX:8418
|
SG |
|
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
|
TW |
|
V
|
Veidekke ASA
OSE:VEI
|
NO |
|
First Industrial Realty Trust Inc
NYSE:FR
|
US |
|
OIO Holdings Ltd
SGX:KUX
|
SG |
|
Samvardhana Motherson International Ltd
NSE:MOTHERSON
|
IN |
|
Meituan
HKEX:3690
|
CN |
|
W
|
Willings Co Ltd
KOSDAQ:313760
|
KR |
|
Mediaone Global Entertainment Ltd
BSE:503685
|
IN |
|
I
|
Inrom Construction Industries Ltd
TASE:INRM
|
IL |
|
Kamdhenu Ltd
NSE:KAMDHENU
|
IN |
|
Nihon Dempa Kogyo Co Ltd
TSE:6779
|
JP |
|
Novo Nordisk A/S
NYSE:NVO
|
DK |
|
P
|
Pebble Beach Systems Group PLC
LSE:PEB
|
UK |
|
V
|
Vietnam Industrial Investments Ltd
ASX:VII
|
AU |
|
V
|
Vesuvius India Ltd
NSE:VESUVIUS
|
IN |
|
X
|
Xometry Inc
NASDAQ:XMTR
|
US |
Income Statement
Earnings Waterfall
Promisia Healthcare Ltd
Promisia Healthcare Ltd
Income Statement
Promisia Healthcare Ltd
Promisia Healthcare Ltd
Currency: NZD
| Dec-2019 | Jun-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-18%
|
6
+3 810%
|
15
+145%
|
19
+28%
|
22
+15%
|
23
+7%
|
23
-3%
|
23
-1%
|
25
+9%
|
31
+26%
|
37
+20%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(1)
|
(1)
|
(7)
|
(15)
|
(16)
|
(18)
|
(21)
|
(21)
|
(22)
|
(22)
|
(29)
|
(34)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(3)
|
(4)
|
(5)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
(5)
|
(11)
|
(14)
|
(16)
|
(18)
|
(17)
|
(17)
|
(18)
|
(24)
|
(29)
|
|
| Operating Income |
(1)
N/A
|
(1)
-7%
|
(1)
+54%
|
0
N/A
|
3
+2 396%
|
4
+59%
|
2
-46%
|
2
-9%
|
1
-46%
|
3
+145%
|
3
-7%
|
3
+13%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
0
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
2
|
1
|
(2)
|
(2)
|
|
| Non-Reccuring Items |
(1)
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
(0)
|
5
|
7
|
2
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
|
| Pre-Tax Income |
(2)
N/A
|
(1)
+42%
|
(0)
+82%
|
(0)
-46%
|
2
N/A
|
2
+24%
|
0
-81%
|
(0)
N/A
|
3
N/A
|
9
+198%
|
7
-24%
|
1
-78%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(2)
|
(1)
|
0
|
(0)
|
2
|
3
|
1
|
(0)
|
1
|
7
|
7
|
1
|
|
| Net Income (Common) |
(2)
N/A
|
(1)
+42%
|
0
N/A
|
(0)
N/A
|
2
N/A
|
3
+23%
|
1
-72%
|
0
-77%
|
2
+935%
|
8
+363%
|
7
-10%
|
1
-85%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0.05
N/A
|
0
N/A
|
0.02
N/A
|
0
N/A
|
0.02
N/A
|
0.31
+1 450%
|
0.12
-61%
|
0.03
-75%
|
|
Switch to:
Switch to:
See Also
Discover More
